Nordic Rebalance contributes to GALAXY WP1.
The latest innovation from Nordic Rebalance is a dietary treatment for IBS and ulcerative colitis, where a microbial fermented FSMP product provides essential nutrients including short chain fatty acids to colonocytes. The effect of the treatment on ulcerative colitis is documented in two scientific clinical trials which are conducted by Nordic Rebalance in collaboration with a number of internationally recognized Danish chief physicians and professors.
The technology of Nordic Rebalance is subject to patents and patent applications in the USA, Canada, Europe, Australia and Japan.
The office for Sales & Marketing is in Lund, Sweden at Medicon Village – a science park that offers a growth environment for over 120 organizations in life science, and the office for Research & Development is in Hilleröd, Denmark at C4 Videncenter.
